The full form of ALK is anaplastic lymphoma kinase.
According to the reference, ALK was first identified in lymphoma. However, most ALK-positive cancers occur in non-small cell lung cancer (NSCLC). The ALK gene plays a role in the development of the gut and nervous system during embryonic development, and it typically turns off before birth (02-Oct-2024).
